-
with type 1 diabetes. This allows us to study the involvement of neutrophils in both blood and pancreatic tissue and to assess their potential as effector, predictive, and therapeutic targets. In
-
in more detail for targeted treatment adaptations. Key challenges to disentangle risk factors for neurocognitive impairment in patients include tumour size, location, treatment specifics, age, sex, and
-
equity between population groups. To address these questions, the researcher will be able to apply advanced health economic methods and make use of valuable datasets that longitudinally track Belgian
-
of inhalant allergens.• Comparing clinical outcomes of symptomatic treatment versus AIT in sensitized military personnel.• Validating a novel diagnostic method using S.P.A.T. as a tool to track allergen